The 9th Conference on Retroviruses and Opportunistic Infections

The Body Covers:

The 9th Conference on Retroviruses and Opportunistic Infections

Washington State Convention and Trade Center, Seattle, Washington

February 24-28, 2002

Other Reports and Articles

The Body's Conference Summaries
Day One Monday, February 25	Day Two Tuesday, February 26	Day Three Wednesday, February 27	Day Four Thursday, February 28
Immune Reconstitution and Immunologic Responses to Antiretroviral Therapies: Implications for Therapeutic Strategies Antiretroviral Chemotherapy: New Agents Opportunistic Infections and Complications of Antiretroviral Therapy IL-2 and Other Forms of Immunotherapy Treatment Interruption	Antiretroviral Chemotherapy: Combination Therapy, Drug Resistance, and Treatment Interruption Controversies in Antiretroviral Therapy Adherence to Therapy Resistance to Antiretroviral Chemotherapeutic Agents Switch Studies/Treatment of Lipodystrophy Syndromes	New Insights Into Mechanisms of HIV-1 Resistance to Reverse Transcriptase Inhibitors Treatment of Patients With Drug-Resistant Virus Antiretroviral Chemotherapy: Pathogenesis of Primary HIV Infection Pediatric/Maternal-Fetal HIV Infection and Issues in HIV-Infected Women Antiretroviral Chemotherapy in Drug-Naive Patients Pharmacokinetics of Antiretroviral Drugs	Late Breakers II Selected Highlights From Retrovirus


Brian A. Boyle, M.D., J.D.	Cal Cohen, M.D., M.S.	Edwin DeJesus, M.D.	Keith Henry, M.D.	Mark Holodniy, M.D., F.A.C.P., C.I.C.

Matthew R. Leibowitz, M.D.	Andrew T. Pavia, M.D.	Paul E. Sax, M.D.	Pablo Tebas, M.D.	Benjamin Young, M.D., Ph.D.

The Body's next-day conference summaries have been reported exclusively by some of the most outstanding HIV specialists in the U.S.A.: Brian A. Boyle, M.D., J.D.; Cal Cohen, M.D., M.S.; Edwin DeJesus, M.D.; Keith Henry, M.D.; Mark Holodniy, M.D., F.A.C.P., C.I.C.; Matthew R. Leibowitz, M.D.; Andrew T. Pavia, M.D.; Paul E. Sax, M.D.; Pablo Tebas, M.D.; and Benjamin Young, M.D., Ph.D.

Funding for this conference coverage at The Body is provided, in part, by unrestricted educational grants from Boehringer Ingelheim Pharmaceuticals and GlaxoSmithKline.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.